Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK

by Emilie Clay, Aurélien Jamotte, Peter Verhamme, Alexander T. Cohen, Ben. A. Van Hout, Pearl. Gumbs
Published 2018-01-01

Quantifying cost-effectiveness of controlling nosocomial spread of antibiotic-resistant bacteria: the case of MRSA.

by Marjan W M Wassenberg, G Ardine de Wit, Ben A van Hout, Marc J M Bonten
Published 2010-01-01

Costs in the Last Year of Life in the Netherlands

by Tom Stooker, Joost W. van Acht, Erik M. van Barneveld, René C.J.A. van Vliet, Ben A. van Hout, Dick J. Hessing, Jan J.V. Busschbach
Published 2001-02-01